In detail, using a cutoff of 5%, PD-L1 positivity was found to increase from 24% to 71% on immune cells and from 9.5% to 38% on tumor cells, before and after TPF induction chemotherapy, respectively [36]. Here, CD274 is linked to neoplasm.